The Canadian drugmaker Valeant said it would be willing to raise its takeover bid for Allergan by almost 12 percent, which would mean $200 or more per share for the maker of Botox. The letter to Allergan's board Monday did not break down the exact terms...
23.16 | 0
komentar | Read More